Colorectal cancer, also called bowel cancer, is one of the most common and deadly forms of cancer in the world.
Every year, millions of people are diagnosed with the disease, and many lose their lives because the cancer is often found at a late stage or becomes difficult to treat.
Although doctors and scientists have learned a great deal about colorectal cancer over the years, many questions still remain about exactly how the disease begins and why it behaves differently from one patient to another.
A major new study has now provided the most detailed picture yet of the genetic changes linked to colorectal cancer. The research was led by scientists from several leading universities in the United Kingdom, including The Institute of Cancer Research in London, the University of Oxford, and the University of Manchester.
Their findings were published in the journal Nature and are being seen as an important step toward improving the prevention, diagnosis, and treatment of bowel cancer.
Cancer develops when changes, called mutations, happen in the genes inside our cells. Genes are like instruction manuals that tell cells when to grow, divide, and die. Sometimes these instructions become damaged.
When that happens, cells may begin growing uncontrollably and form tumors. In some cases, cancer cells can spread to other parts of the body.
Scientists have known for years that certain gene mutations can lead to colorectal cancer, but they suspected that many important genetic changes had not yet been discovered. To investigate this, the researchers examined information from 2,023 bowel cancer samples collected through the 100,000 Genomes Project.
This project, created by Genomics England and NHS England, is one of the world’s largest efforts to study human genes and understand how genetic information can improve healthcare.
By analyzing this enormous amount of data, the researchers discovered more than 250 genes that appear to play important roles in colorectal cancer. Most of these genes had never before been linked to the disease. This means scientists now have hundreds of new clues that could help explain how bowel cancer develops and progresses.
The study also revealed that colorectal cancer is not a single disease. Instead, it can be divided into different genetic sub-groups. The researchers identified four major sub-groups based on their genetic features.
These groups appear to grow differently and are linked to different outcomes for patients. Some patients may have forms of the disease that respond well to treatment, while others may develop more aggressive cancers that require different approaches.
In addition to the four major groups, the researchers found several rare sub-groups of colorectal cancer. Although these uncommon forms of the disease affect fewer people, understanding them could still be extremely important. In the future, they may require special treatments designed specifically for their unique genetic changes.
Another interesting discovery was that different parts of the colon can develop different types of genetic mutations. The researchers also noticed that certain genetic changes were more common in younger patients with colorectal cancer.
The reasons are not yet fully understood, but scientists think environmental factors may play a role. Lifestyle habits such as smoking, diet, and other exposures could potentially influence how these mutations develop.
The findings may also help speed up the search for better treatments. Some of the mutations discovered in this study might be treated with medicines that are already approved for other forms of cancer.
If these drugs prove effective in colorectal cancer patients, doctors may be able to use existing treatments in new ways rather than waiting for entirely new medicines to be developed.
Professor Ian Tomlinson from the University of Oxford said the findings could help doctors better predict how patients are likely to do and choose treatments based on each person’s genetic profile. This approach, often called personalized medicine, aims to match patients with therapies that are most likely to work for their specific form of cancer.
Professor Richard Houlston from The Institute of Cancer Research in London said the study offers a much clearer picture of how colorectal cancer develops and why different patients respond differently to treatment. He hopes this knowledge will eventually lead to more precise and effective care.
Professor David Wedge from the University of Manchester noted that this work is one of the first major discoveries to emerge from the 100,000 Genomes Project. He believes many more important findings about cancer and other diseases are likely to come from this large genetic database in the future.
The study also explored another fascinating area of research. Dr. Henry Wood from the University of Leeds explained that the scientists examined the microbiome, which refers to the enormous community of bacteria and viruses living inside our digestive system.
This is the first time researchers have studied the microbiome in such a large group of colorectal cancer patients. The findings suggest that gut microbes may influence the development and behavior of bowel cancer and could one day become targets for new treatments.
Overall, this landmark study greatly expands our understanding of colorectal cancer. By uncovering hundreds of previously unknown genes and identifying different genetic forms of the disease, the research brings scientists closer to developing more personalized treatments and improving outcomes for patients around the world.
If you care about cancer, please read studies that a low-carb diet could increase overall cancer risk, and vitamin D supplements could strongly reduce cancer death.
For more information about health, please see recent studies about how drinking milk affects the risks of heart disease and cancer and results showing higher intake of dairy foods linked to higher prostate cancer risk.
Copyright © 2026 Knowridge Science Report. All rights reserved.
